{"address1": "5 Science Park", "address2": "395 Winchester Avenue", "city": "New Haven", "state": "CT", "zip": "06511", "country": "United States", "phone": "203 535 1456", "website": "https://www.arvinas.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company engineers proteolysis targeting chimeras (PROTAC) targeted protein degraders that are designed to harness the body's own natural protein disposal system to degrade and remove disease-causing proteins. Its product pipeline includes Bavdegalutamide and ARV-766, investigational orally bioavailable PROTAC protein degraders for the treatment of men with metastatic castration-resistant prostate cancer, which are in Phase 3 clinical trials; and ARV-471, an orally bioavailable estrogen receptor degrading PROTAC targeted protein degrader for the treatment of patients with locally advanced or metastatic estrogen receptor+/human epidermal growth factor receptor 2-breast cancer, which is Phase 3 clinical trial. The company's products also consists ARV 393, orally bioavailable PROTAC designed to degrade BCL6, a transcriptional repressor and a key regulator of normal B-cell maturation and differentiation processes which is in Phase 1 first-in-human clinical trial; ARV 102 for the treatment of neurodegenerative diseases, which is in Phase 1 clinical trial; and KRAS G12D program is in preclinical development for pancreatic and colorectal cancers. Arvinas, Inc. has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., Carrick Therapeutics Limited, and Bayer AG. The company was founded in 2013 and is based in New Haven, Connecticut.", "fullTimeEmployees": 430, "companyOfficers": [{"maxAge": 1, "name": "Dr. John G. Houston Ph.D.", "age": 63, "title": "Chairperson, CEO & President", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 1144497, "exercisedValue": 0, "unexercisedValue": 12278804}, {"maxAge": 1, "name": "Dr. Ian  Taylor Ph.D.", "age": 62, "title": "President of Research & Development and Chairman of Scientific Advisory Board", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 732256, "exercisedValue": 0, "unexercisedValue": 1344633}, {"maxAge": 1, "name": "Mr. Andrew R. Saik", "age": 55, "title": "CFO & Treasurer", "yearBorn": 1969, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David K. Loomis M.B.A.", "age": 50, "title": "VP & Chief Accounting Officer", "yearBorn": 1974, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Angela M. Cacace Ph.D.", "age": 56, "title": "Chief Scientific Officer", "yearBorn": 1968, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jared M. Freedberg J.D.", "age": 55, "title": "General Counsel & Corporate Secretary", "yearBorn": 1969, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Steve  Weiss", "age": 54, "title": "Senior VP & Chief Human Resources Officer", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Randy  Teel Ph.D.", "age": 44, "title": "Chief Business Officer", "yearBorn": 1980, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lisa  Sinclair", "title": "Senior Vice President of Corporate Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul  McInulty", "title": "Senior Vice President of Regulatory Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 3, "boardRisk": 9, "compensationRisk": 8, "shareHolderRightsRisk": 9, "overallRisk": 8, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.02, "open": 7.03, "dayLow": 6.845, "dayHigh": 7.35, "regularMarketPreviousClose": 7.02, "regularMarketOpen": 7.03, "regularMarketDayLow": 6.845, "regularMarketDayHigh": 7.35, "payoutRatio": 0.0, "beta": 1.962, "forwardPE": -1.5085838, "volume": 2695578, "regularMarketVolume": 2695578, "averageVolume": 1894913, "averageVolume10days": 2653230, "averageDailyVolume10Day": 2653230, "bid": 6.98, "ask": 7.06, "bidSize": 3, "askSize": 2, "marketCap": 483466496, "fiftyTwoWeekLow": 6.84, "fiftyTwoWeekHigh": 39.58, "priceToSalesTrailing12Months": 1.835484, "fiftyDayAverage": 14.8296, "twoHundredDayAverage": 22.2681, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -546233792, "profitMargins": -0.75513, "floatShares": 53685383, "sharesOutstanding": 68771904, "sharesShort": 8900480, "sharesShortPriorMonth": 11540484, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.1294, "heldPercentInsiders": 0.07618, "heldPercentInstitutions": 1.1028199, "shortRatio": 3.14, "shortPercentOfFloat": 0.1318, "impliedSharesOutstanding": 74355904, "bookValue": 8.164, "priceToBook": 0.8610976, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -198900000, "trailingEps": -2.77, "forwardEps": -4.66, "enterpriseToRevenue": -2.074, "enterpriseToEbitda": 2.224, "52WeekChange": -0.8178284, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 7.03, "targetHighPrice": 110.0, "targetLowPrice": 10.0, "targetMeanPrice": 43.31579, "targetMedianPrice": 32.0, "recommendationMean": 1.63636, "recommendationKey": "buy", "numberOfAnalystOpinions": 19, "totalCash": 1039400000, "totalCashPerShare": 15.114, "ebitda": -245600000, "totalDebt": 9700000, "quickRatio": 4.583, "currentRatio": 4.644, "totalRevenue": 263400000, "debtToEquity": 1.727, "revenuePerShare": 3.663, "returnOnAssets": -0.13053, "returnOnEquity": -0.32561, "grossProfits": 263400000, "freeCashflow": -99275000, "operatingCashflow": -259300000, "grossMargins": 1.0, "ebitdaMargins": -0.93241996, "operatingMargins": -0.98310995, "financialCurrency": "USD", "symbol": "ARVN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1538055000000, "shortName": "Arvinas, Inc.", "longName": "Arvinas, Inc.", "corporateActions": [], "regularMarketTime": 1743537601, "exchange": "NMS", "messageBoardId": "finmb_243040896", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.1424534, "regularMarketPrice": 7.03, "cryptoTradeable": false, "marketState": "PRE", "regularMarketChange": 0.010000229, "regularMarketDayRange": "6.845 - 7.35", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1894913, "fiftyTwoWeekLowChange": 0.19000006, "fiftyTwoWeekLowChangePercent": 0.027777785, "fiftyTwoWeekRange": "6.84 - 39.58", "fiftyTwoWeekHighChange": -32.550003, "fiftyTwoWeekHighChangePercent": -0.8223851, "fiftyTwoWeekChangePercent": -81.782845, "earningsTimestamp": 1739275204, "earningsTimestampStart": 1746102600, "earningsTimestampEnd": 1746448200, "earningsCallTimestampStart": 1739278800, "earningsCallTimestampEnd": 1739278800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.77, "epsForward": -4.66, "epsCurrentYear": -4.05308, "priceEpsCurrentYear": -1.7344835, "fiftyDayAverageChange": -7.7996, "fiftyDayAverageChangePercent": -0.5259481, "twoHundredDayAverageChange": -15.2381, "twoHundredDayAverageChangePercent": -0.68430173, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.6 - Buy", "displayName": "Arvinas", "trailingPegRatio": null}